作者: Jerome B. Zeldis
DOI:
关键词:
摘要: Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administration an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, prodrug thereof, alone in combination with second active ingredient, transplantation blood cells. ingredients capable affecting cell production. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use invention also